| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Voyager Therapeutics, Inc. | VP, Finance | Common Stock | 52,458 | $375,075 | $7.15 | 21 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | 21 Mar 2022 | 2 | -$21,972 | 4 | VP, Finance | 23 Mar 2022, 18:36 |
| VYGR | Voyager Therapeutics, Inc. | 17 Feb 2022 | 1 | -$2,801 | 4 | VP, Finance | 22 Feb 2022, 15:35 |
| VYGR | Voyager Therapeutics, Inc. | 11 Feb 2022 | 1 | -$1,213 | 4 | VP, Finance | 15 Feb 2022, 15:40 |
| VYGR | Voyager Therapeutics, Inc. | 13 Jan 2022 | 2 | $0 | 4 | VP, Finance | 18 Jan 2022, 19:06 |
| VYGR | Voyager Therapeutics, Inc. | 03 Jan 2022 | 3 | -$2,434 | 4 | VP, Finance | 14 Jan 2022, 17:14 |
| VYGR | Voyager Therapeutics, Inc. | 26 Nov 2021 | 2 | $0 | 4 | VP, Finance | 30 Nov 2021, 15:34 |
| VYGR | Voyager Therapeutics, Inc. | 26 Nov 2021 | 0 | $0 | 3 | Vice President, Finance | 30 Nov 2021, 15:33 |